The investigational treatment in this trial though holds promise for patients with anti-dsDNA autoantibodies as 7.6% of these patients in the Lupuzor group went into full remission, compared with none in the placebo treated group
All approaches have their value when used appropriately, for the right person at the right time
Granulosa cells, the predominant somatic cell population in the follicular microenvironment, normally respond to hormonal signals and support the growth of a dominant follicle, which eventually leads to ovulation [4]
They are approved only for type 2 diabetes and weight management under specific NICE guidance, and any use for inflammatory conditions would be considered off-label prescribing
This is why GHK-Cu cycling exists typically 30-60 days on, equal time off
Experts dont yet understand why the drugs work differently in different people, but hormone receptors in our brains likely vary in subtle yet important ways